The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of turnaround time (TAT) of molecular testing on initial treatment (Tx) in newly diagnosed stage 4 non-small cell lung cancer (NSCLC 4): An Integra Connect (IC) retrospective observational study.
 
Mike Gart
Employment - IntegraConnect
Stock and Other Ownership Interests - Becton Dickinson; Boston Scientific (I); Cerner (I); Elanco; Gilead Sciences (I); Thermo Fisher Scientific (I)
 
Lucio N. Gordan
Employment - Florida Cancer Specialists
Leadership - Florida Cancer Specialists
Stock and Other Ownership Interests - American Oncology Network; Florida Cancer Specialists and Research Institute
Honoraria - Ameris Pharma
Consulting or Advisory Role - Illumina; IntegraConnect; Janssen Oncology; Tolmar
 
Rushir J. Choksi
Consulting or Advisory Role - IntegraConnect; Ipsen; Pfizer
 
Daniel P. Petro
Stock and Other Ownership Interests - Affimed Therapeutics; cytoagents; Duo Oncology; Elucida Oncology; ImmunityBio; Sorrento Therapeutics
Consulting or Advisory Role - AstraZeneca/MedImmune; IntegraConnect
 
Jeffrey A. Scott
Employment - IntegraConnect
 
Prateesh Varughese
No Relationships to Disclose
 
Erin Alwon
No Relationships to Disclose
 
Robert E. Smith
Employment - IntegraConnect